| 11932633 |
KRas G12C inhibitors |
Matthew Arnold Marx, Matthew Lee, James F. Blake, Mark Joseph Chicarelli, Jay Bradford Fell +5 more |
2024-03-19 |
| 11834453 |
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors |
Mark Laurence Boys, Bryan Daniel ELLIS, John Gaudino, Ellen Laird, Nicholas Charles LAZZARA +2 more |
2023-12-05 |
| 11634409 |
Compounds for the treatment of BRAF-associated diseases and disorders |
Patrick Barbour, Katie Keaton BROWN, Adam Cook, Dean Russell Kahn, Ellen Laird +7 more |
2023-04-25 |
| 11414404 |
Compounds for the treatment of BRAF-associated diseases and disorders |
Patrick Barbour, Katie Keaton BROWN, Adam Cook, Dean Russell Kahn, Ellen Laird +7 more |
2022-08-16 |
| 11267812 |
KRAS G12C inhibitors |
John P. Fischer, Jay Bradford Fell, James F. Blake, Ronald Jay Hinklin, Macedonio J. Mejia +10 more |
2022-03-08 |
| 11028093 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2021-06-08 |
| 10730880 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2020-08-04 |
| 10669269 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more |
2020-06-02 |
| 10633381 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2020-04-28 |
| 10189845 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2019-01-29 |
| 10125134 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2018-11-13 |
| 9809590 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more |
2017-11-07 |
| 9670208 |
Serine/threonine kinase inhibitors |
James F. Blake, Adam Cook, John Gaudino, Indrani W. Gunawardana, Kevin W. Hunt +11 more |
2017-06-06 |
| 9174981 |
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors |
Mark Laurence Boys, Robert Kirk DeLisle, April L. Kennedy, David A. Mareska, Fredrik P. Marmsater +7 more |
2015-11-03 |
| 8987251 |
Triazolopyridine compounds as PIM kinase inhibitors |
Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Hicks +13 more |
2015-03-24 |
| 8895550 |
Triazolopyridine compounds as PIM kinase inhibitors |
Shelley Allen, Robert Kirk DeLisle, Julie Marie Hicks, Joseph P. Lyssikatos, Fredrik P. Marmsater +3 more |
2014-11-25 |
| 8575145 |
Triazolopyridine compounds as PIM kinase inhibitors |
Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Greschuk +13 more |
2013-11-05 |
| 8557809 |
Triazolopyridine compounds as PIM kinase inhibitors |
Shelley Allen, Robert Kirk DeLisle, Julie Marie Greschuk, Joseph P. Lyssikatos, Fredrik P. Marmsater +3 more |
2013-10-15 |
